219 related articles for article (PubMed ID: 18755239)
1. Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activity.
Tharakan R; Lepont P; Singleton D; Kumar R; Khan S
Mol Cell Endocrinol; 2008 Nov; 295(1-2):70-8. PubMed ID: 18755239
[TBL] [Abstract][Full Text] [Related]
2. PKA-induced resistance to tamoxifen is associated with an altered orientation of ERalpha towards co-activator SRC-1.
Zwart W; Griekspoor A; Berno V; Lakeman K; Jalink K; Mancini M; Neefjes J; Michalides R
EMBO J; 2007 Aug; 26(15):3534-44. PubMed ID: 17627277
[TBL] [Abstract][Full Text] [Related]
3. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha.
Kim JH; Lee MH; Kim BJ; Kim JH; Han SJ; Kim HY; Stallcup MR
J Mol Endocrinol; 2005 Dec; 35(3):449-64. PubMed ID: 16326832
[TBL] [Abstract][Full Text] [Related]
4. MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.
Wei X; Xu H; Kufe D
Mol Cell; 2006 Jan; 21(2):295-305. PubMed ID: 16427018
[TBL] [Abstract][Full Text] [Related]
5. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
Lin Z; Reierstad S; Huang CC; Bulun SE
Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
Balasenthil S; Barnes CJ; Rayala SK; Kumar R
FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
[TBL] [Abstract][Full Text] [Related]
7. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
[TBL] [Abstract][Full Text] [Related]
8. Capacity of type I and II ligands to confer to estrogen receptor alpha an appropriate conformation for the recruitment of coactivators containing a LxxLL motif-Relationship with the regulation of receptor level and ERE-dependent transcription in MCF-7 cells.
Bourgoin-Voillard S; Gallo D; Laïos I; Cleeren A; Bali LE; Jacquot Y; Nonclercq D; Laurent G; Tabet JC; Leclercq G
Biochem Pharmacol; 2010 Mar; 79(5):746-57. PubMed ID: 19879249
[TBL] [Abstract][Full Text] [Related]
9. P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.
Rayala SK; Talukder AH; Balasenthil S; Tharakan R; Barnes CJ; Wang RA; Aldaz CM; Khan S; Kumar R
Cancer Res; 2006 Feb; 66(3):1694-701. PubMed ID: 16452229
[TBL] [Abstract][Full Text] [Related]
10. ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts.
Lambertini E; Tavanti E; Torreggiani E; Penolazzi L; Gambari R; Piva R
J Cell Physiol; 2008 Jul; 216(1):101-10. PubMed ID: 18247370
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
Weitsman GE; Weebadda W; Ung K; Murphy LC
Breast Cancer Res Treat; 2009 Nov; 118(2):269-79. PubMed ID: 18941890
[TBL] [Abstract][Full Text] [Related]
13. Interactions between CCAAT enhancer binding protein delta and estrogen receptor alpha control insulin-like growth factor I (igf1) and estrogen receptor-dependent gene expression in osteoblasts.
Chang W; Parra M; Centrella M; McCarthy TL
Gene; 2005 Jan; 345(2):225-35. PubMed ID: 15716114
[TBL] [Abstract][Full Text] [Related]
14. The human estrogen receptor alpha dimer binds a single SRC-1 coactivator molecule with an affinity dictated by agonist structure.
Margeat E; Poujol N; Boulahtouf A; Chen Y; Müller JD; Gratton E; Cavailles V; Royer CA
J Mol Biol; 2001 Feb; 306(3):433-42. PubMed ID: 11178903
[TBL] [Abstract][Full Text] [Related]
15. Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain.
Clark DE; Poteet-Smith CE; Smith JA; Lannigan DA
EMBO J; 2001 Jul; 20(13):3484-94. PubMed ID: 11432835
[TBL] [Abstract][Full Text] [Related]
16. The F-domain of estrogen receptor-alpha inhibits ligand induced receptor dimerization.
Yang J; Singleton DW; Shaughnessy EA; Khan SA
Mol Cell Endocrinol; 2008 Nov; 295(1-2):94-100. PubMed ID: 18762230
[TBL] [Abstract][Full Text] [Related]
17. Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells.
Papoutsi Z; Zhao C; Putnik M; Gustafsson JA; Dahlman-Wright K
J Mol Endocrinol; 2009 Aug; 43(2):65-72. PubMed ID: 19376833
[TBL] [Abstract][Full Text] [Related]
18. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
19. 17β-Estradiol-induced cell proliferation requires estrogen receptor (ER) α monoubiquitination.
La Rosa P; Pesiri V; Marino M; Acconcia F
Cell Signal; 2011 Jul; 23(7):1128-35. PubMed ID: 21356307
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of GATA2-dependent transactivation of the TSHbeta gene by ligand-bound estrogen receptor alpha.
Nagayama K; Sasaki S; Matsushita A; Ohba K; Iwaki H; Matsunaga H; Suzuki S; Misawa H; Ishizuka K; Oki Y; Noh JY; Nakamura H
J Endocrinol; 2008 Oct; 199(1):113-25. PubMed ID: 18653622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
